BAXTER INTL INC's ticker is BAX and the CUSIP is 071813109. A total of 1,080 filers reported holding BAXTER INTL INC in Q3 2021. The put-call ratio across all filers is 0.84 and the average weighting 0.2%.
About BAXTER INTL INC
Baxter International Inc. is a global healthcare company that specializes in developing and manufacturing medical products and therapies. The company has a long history of innovation and has been at the forefront of developing life-saving treatments for patients around the world.
Baxter's product portfolio includes a wide range of medical devices, pharmaceuticals, and biotechnology products. The company's products are used in hospitals, clinics, and other healthcare settings to treat a variety of conditions, including hemophilia, immune disorders, kidney disease, and other chronic and acute medical conditions.
Baxter's commitment to innovation has helped the company maintain a strong position in the healthcare industry. The company invests heavily in research and development, and has a strong pipeline of new products in development.
Baxter's leadership team is also a key strength of the company. The CEO, José Almeida, has a strong track record of success in the healthcare industry, and has been instrumental in driving the company's growth and success.
Overall, Baxter International Inc. is a strong and innovative company that is well-positioned to continue delivering value to patients, healthcare providers, and investors alike. With a strong product portfolio, a commitment to innovation, and a talented leadership team, Baxter is a company that investors should keep an eye on in the years to come.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2024 | $40,108,524 | -5.4% | 1,040,758 | +9.5% | 0.03% | -15.8% |
Q1 2024 | $42,415,390 | +37.5% | 950,231 | +19.1% | 0.04% | +8.6% |
Q4 2023 | $30,847,317 | +116.2% | 797,913 | +111.1% | 0.04% | +94.4% |
Q3 2023 | $14,267,607 | +4.3% | 378,050 | +26.0% | 0.02% | +5.9% |
Q2 2023 | $13,673,103 | -29.9% | 300,112 | -37.6% | 0.02% | -37.0% |
Q1 2023 | $19,496,502 | -4.3% | 480,683 | +50.7% | 0.03% | -12.9% |
Q4 2022 | $20,380,253 | -99.9% | 318,866 | +12.0% | 0.03% | +19.2% |
Q3 2022 | $16,260,119,000 | -34.0% | 284,670 | -25.8% | 0.03% | -31.6% |
Q2 2022 | $24,628,801,000 | -3.2% | 383,447 | +16.9% | 0.04% | +11.8% |
Q1 2022 | $25,431,337,000 | +117.3% | 327,977 | +140.6% | 0.03% | +100.0% |
Q4 2021 | $11,703,426,000 | -42.0% | 136,340 | -45.6% | 0.02% | -41.4% |
Q3 2021 | $20,165,490,000 | +32.1% | 250,721 | +32.2% | 0.03% | +45.0% |
Q2 2021 | $15,268,757,000 | -32.2% | 189,674 | -29.0% | 0.02% | -39.4% |
Q1 2021 | $22,525,106,000 | +148.6% | 267,075 | +136.5% | 0.03% | +94.1% |
Q4 2020 | $9,060,540,000 | -61.2% | 112,918 | -61.1% | 0.02% | -48.5% |
Q3 2020 | $23,345,604,000 | -59.6% | 290,296 | -56.7% | 0.03% | -67.6% |
Q2 2020 | $57,769,484,000 | +160.9% | 670,958 | +146.0% | 0.10% | +126.7% |
Q1 2020 | $22,145,303,000 | +141.3% | 272,759 | +149.4% | 0.04% | +164.7% |
Q4 2019 | $9,179,051,000 | -46.8% | 109,375 | -44.5% | 0.02% | -45.2% |
Q3 2019 | $17,262,992,000 | -35.7% | 196,963 | -35.3% | 0.03% | -42.6% |
Q2 2019 | $26,861,316,000 | +31.4% | 304,217 | +33.4% | 0.05% | +22.7% |
Q1 2019 | $20,438,407,000 | -26.9% | 228,000 | -42.4% | 0.04% | -33.3% |
Q4 2018 | $27,940,919,000 | -71.3% | 395,597 | -68.7% | 0.07% | -54.2% |
Q3 2018 | $97,303,461,000 | +90.8% | 1,262,206 | +82.7% | 0.14% | +69.4% |
Q2 2018 | $51,002,691,000 | +13.7% | 690,719 | +0.2% | 0.08% | +1.2% |
Q1 2018 | $44,838,186,000 | +131.8% | 689,394 | +130.4% | 0.08% | +147.1% |
Q4 2017 | $19,341,452,000 | -58.5% | 299,218 | -59.7% | 0.03% | -70.2% |
Q3 2017 | $46,567,906,000 | -13.4% | 742,118 | -16.4% | 0.11% | -29.6% |
Q2 2017 | $53,770,357,000 | +197.8% | 888,179 | +155.1% | 0.16% | +237.5% |
Q1 2017 | $18,054,334,000 | +132.0% | 348,136 | +98.3% | 0.05% | +33.3% |
Q4 2016 | $7,783,629,000 | +182.0% | 175,588 | +202.8% | 0.04% | +227.3% |
Q3 2016 | $2,760,229,000 | -97.3% | 57,988 | -97.5% | 0.01% | -97.6% |
Q2 2016 | $103,147,951,000 | +839.6% | 2,281,030 | +753.5% | 0.46% | +910.9% |
Q1 2016 | $10,978,384,000 | +35.4% | 267,244 | +25.7% | 0.05% | +130.0% |
Q4 2015 | $8,109,546,000 | -37.5% | 212,570 | -46.2% | 0.02% | -37.5% |
Q3 2015 | $12,969,278,000 | +5.1% | 394,803 | +123.6% | 0.03% | -5.9% |
Q2 2015 | $12,345,372,000 | -6.8% | 176,539 | -8.7% | 0.03% | -8.1% |
Q1 2015 | $13,247,010,000 | -39.2% | 193,387 | -34.9% | 0.04% | -51.9% |
Q4 2014 | $21,786,552,000 | +2.8% | 297,265 | +1.0% | 0.08% | +327.8% |
Q3 2014 | $21,198,146,000 | +39.6% | 294,447 | +43.4% | 0.02% | +28.6% |
Q2 2014 | $15,186,340,000 | -25.6% | 205,361 | -25.0% | 0.01% | -6.7% |
Q1 2014 | $20,398,776,000 | -58.0% | 273,715 | -60.9% | 0.02% | -16.7% |
Q4 2013 | $48,603,531,000 | +47.1% | 700,390 | +42.7% | 0.02% | -25.0% |
Q3 2013 | $33,036,725,000 | +1484.5% | 490,928 | +1531.0% | 0.02% | +2300.0% |
Q2 2013 | $2,085,030,000 | – | 30,100 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Third Point | 36,000,000 | $2,658,240,000 | 18.52% |
SECTOR GAMMA AS | 721,058 | $53,243,000 | 8.85% |
SUVRETTA CAPITAL MANAGEMENT, LLC | 2,747,061 | $202,843,000 | 5.38% |
Veritas Asset Management LLP | 8,852,005 | $653,632,000 | 5.36% |
Knowledge Leaders Capital, LLC | 79,384 | $5,862,000 | 4.39% |
HealthCor Management, L.P. | 1,800,000 | $132,912,000 | 4.22% |
Progressive Investment Management Corp | 79,282 | $5,854,000 | 3.78% |
13D Management LLC | 200,318 | $14,791,000 | 3.77% |
ARGENT CAPITAL MANAGEMENT LLC | 1,288,236 | $95,123,000 | 3.42% |
Chiron Investment Management, LLC | 612,787 | $45,248,000 | 3.12% |